FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Pharmacokinetics and clinical efficacy of acetaminophen (par...
Equine veterinary journal2022; 55(3); 524-533; doi: 10.1111/evj.13601

Pharmacokinetics and clinical efficacy of acetaminophen (paracetamol) in adult horses with mechanically induced lameness.

Abstract: Acetaminophen has been used clinically in horses alone or combined with traditional non-steroidal anti-inflammatory drugs for treatment of musculoskeletal pain in horses. Objective: To determine the pharmacokinetics and efficacy of acetaminophen at two doses in horses with mechanically induced lameness compared with phenylbutazone or placebo control. Methods: In vivo experiment. Methods: Nine healthy mares with mechanical lameness induced via a reversible sole pressure horseshoe model were treated with acetaminophen (20 mg/kg PO; A20), acetaminophen (30 mg/kg PO; A30), phenylbutazone (2.2 mg/kg, PO; PB) and oral placebo (C) in a randomised four-way Latin square model. Plasma concentrations for A20 and A30 were analysed via LC-MS/MS and noncompartmental pharmacokinetic analysis. Heart rate and heart rate variability were measured using a portable telemetry. Lameness was scored by three blinded boarded equine surgeons using the AAEP and 10-point scales. Results: Mean maximum plasma concentration (C ) for A20 was 20.01 μg/ml within 0.66 h (T ) after administration; The mean C for A30 was 30.02 μg/ml with a T of 0.43 h. Post-treatment heart rate for A30 was significantly lower than A20 at 1 and 7 h; lower than PB at 2, 3, 4.5 and 7 h; lower than C at 2, 3.5, 4.5, 6, 7 and 8 h. 10-point Lameness scores were significantly improved for A30 than C at 2 and 4 h post-treatment; PB was significantly improved than C at 8 h post treatment. There were no significant differences in lameness between A20, A30 and PB. Conclusions: Small sample size, lack of objective lameness measurement. Conclusions: Acetaminophen at 30 mg/kg produced a more rapid improvement in lameness scores and heart rate compared with other treatments in this model. Further evaluation of the pharmacokinetics and safety of repeated oral dosing of acetaminophen at 30 mg/kg is needed to determine clinical utility. Unassigned: Acetaminofeno tem sido usado rotineiramente em cavalos com dor musculoesquelética, tanto como terapia solo quanto em associação com outros anti-inflamatórios não esteroides tradicionais. Objective: Determinar a farmacocinética e eficácia de duas doses de acetaminofeno em cavalos com claudicação mecanicamente induzida, e comparar com fenilbutazona e placebo. Unassigned: Estudo randomizado, cego e controlado utilizando quadrado latino. Methods: Nove éguas adultas com claudicação induzida mecanicamente pelo método de aplicação de pressão na sola através de ferradura foram tratadas com acetaminofeno (20 mg/kg VO; A20), acetaminofeno (30 mg/kg VO; A30), fenilbutazona (2.2 mg/kg, VO; PB) e placebo oral (C) em um estudo quadrado latino de forma randômica. Concentração plasmática dos grupos A20 e A30 foram analisadas pelo método LC-MS/MS e análise farmacocinética não compartimentar. Frequência cardíaca e variação da frequência cardíaca foram mensuradas usando telemetria portátil. O grau de claudicação foi avaliado usando a escala de 10 pontos da AAEP por três cirurgiões especialistas (board-certified) que estavam cegos ao tratamento. Results: A média máxima da concentração plasmática (C ) do grupo A20 foi 20.01 μg/ml dentro de 0.66 h (T ) da administração. A média C do grupo A30 foi 30.02 μg/ml dentro da T de 0.43 h. A frequência cardíaca do grupo A30 foi significativamente mais baixa do que a do grupo A20 nos momentos 1 e 7 h; mais baixa do que o grupo PB nos momentos 2, 3, 4.5 e 7 h; e mais baixa do que as do grupo C nos momentos 2, 3.5, 4.5, 6, 7 e 8 h. O grau de claudicação diminuiu significativamente no grupo A30 quando comparado com o grupo C nos momentos 2 e 4 h pós tratamento, e no grupo PB quando comparado com o grupo C no momento 8 h pós tratamento. Não houve diferença significativa em grau de claudicação quando os grupos A20, A30 e PB foram comparados. PRINCIPAIS LIMITAÇÕES: Número pequeno de animais, ausência de mensuração de claudicação objetiva. CONCLUSÕES: A dose de 30 mg/kg de acetaminofeno proporcionou uma superior melhora na escala de claudicação e frequência cardíaca quando comparada com os outros tratamentos avaliados neste estudo. Mais informações sobre a farmacocinética e efeitos da repetida dosagem de 30 mg/kg de acetaminofeno precisam ser avaliadas para determinar a sua aplicabilidade clínica.
© 2022 EVJ Ltd.
Get Full Text
Publication Date: 2022-06-24 PubMed ID: 35633196DOI: 10.1111/evj.13601Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the effectiveness and pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes a drug) of acetaminophen (paracetamol) on treating mechanically induced lameness in horses. Higher doses of acetaminophen resulted in rapid improvement in lameness scores and heart rate compared with other treatments.

Methods

  • The study used nine healthy adult mares (female horses) with mechanically induced lameness. The lameness was induced by applying pressure on the sole of the horse’s foot using a special horseshoe.
  • These horses were then given acetaminophen (at 20 mg/kg and 30 mg/kg), phenylbutazone (a traditional non-steroidal anti-inflammatory drug), or a placebo in a randomized sequence.
  • Plasma concentration of acetaminophen at the two doses was measured using liquid chromatography-mass spectrometry (LC-MS/MS), a widely accepted method for drug detection. The study also made use of noncompartmental pharmacokinetic analysis which involves analyzing the concentration of the drug in the bloodstream over time.
  • Heart rate and heart rate variability were also measured using portable telemetry, and lameness was scored using standard scales by three blinded veterinary surgeons.

Results

  • The plasma concentration peak time for the 30 mg/kg dose of acetaminophen (A30) was shorter (0.43 hr) compared to the 20 mg/kg dose (A20) which was 0.66 hr.
  • The heart rate post-treatment with A30 was significantly lower than A20 at 1 and 7 hours, lower than phenylbutazone (PB) at 2, 3, 4.5 and 7 hours, and lower than placebo (C) at multiple time points. This suggests that A30 had a relaxing effect on horses.
  • Lameness scores were significantly improved for A30 compared to the placebo at 2 and 4 hours post-treatment. At 8 hours post-treatment, lameness scores were significantly better for phenylbutazone than the placebo.
  • There were no significant differences in lameness between A20, A30, and PB, indicating a beneficial effect of the drug under study.

Limitations & Conclusions

  • The study was small and lacked objective lameness measurement. More research with larger sample sizes may be needed to verify these findings.
  • In conclusion, it was found that 30 mg/kg dose of acetaminophen helped in rapid improvement in lameness and decrease in heart rate, making it potentially beneficial for managing musculoskeletal pain in horses.
  • Future studies need to further evaluate pharmacokinetics and safety of repeatedly administering the 30 mg/kg dose of acetaminophen to confirm these findings and establish its clinical applicability.

Cite This Article

APA
Mercer MA, McKenzie HC, Byron CR, Pleasant RS, Bogers SH, Council-Troche RM, Werre SR, Burns T, Davis JL. (2022). Pharmacokinetics and clinical efficacy of acetaminophen (paracetamol) in adult horses with mechanically induced lameness. Equine Vet J, 55(3), 524-533. https://doi.org/10.1111/evj.13601

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 55
Issue: 3
Pages: 524-533

Researcher Affiliations

Mercer, Melissa A
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
McKenzie, Harold C
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Byron, Christopher R
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Pleasant, Robert S
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Bogers, Sophie H
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Council-Troche, Roberto M
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Werre, Stephen R
  • Department of Population Health Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Burns, Travis
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.
Davis, Jennifer L
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia, USA.

MeSH Terms

  • Animals
  • Female
  • Acetaminophen / therapeutic use
  • Chromatography, Liquid / veterinary
  • Horse Diseases / drug therapy
  • Horses
  • Lameness, Animal / drug therapy
  • Phenylbutazone / pharmacokinetics
  • Tandem Mass Spectrometry / veterinary
  • Treatment Outcome

Grant Funding

  • The Virginia Horse Industry Board

References

This article includes 35 references
  1. Kane A, Traub-Dargatz J, Losinger WC, Garber LP. The occurrence and causes of lameness and laminitis in the US horse population.. Proc Am Assoc Equine Practnrs 2000;46:277-80.
  2. USDA. NAHMS equine 2015 report 3: equine management and select equine health conditions in the United States [internet]; 2015. Available from: https://www.aphis.usda.gov/animal_health/nahms/equine/downloads/equine15/Eq2015_Rept3.pdf
  3. MacAllister CG, Morgan SJ, Borne AT, Pollet RA. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.. J Am Vet Med Assoc 1993;202(1):71-7.
  4. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.. Inflammopharmacology 2013;21(3):201-32.
  5. Gonzalez-Perez A, Rodriguez LA. Upper gastrointestinal complications among users of paracetamol.. Basic Clin Pharmacol Toxicol 2006;98(3):297-303.
  6. Foreman JH, Foreman CB. Medical alternatives to conventional cyclooxygenase inhibitors for treatment of acute foot pain in a reversible lameness model in horses.. In: ACVIM Forum; 2015.
  7. West E, Bardell D, Morgan R, Senior M. Use of acetaminophen (paracetamol) as a short-term adjunctive analgesic in a laminitic pony.. Vet Anaesth Analg 2011;38(5):521-2.
  8. Foreman SE. 30-day oral acetaminophen tolerance in adult horses.. In: Augustana College; 2018.
  9. Foreman J, Foreman C, Bergstrom B. Acetaminophen/paracetamol efficacy in a reversible model of equine foot pain.. Proceedings of American Association of Equine Practitioners 2016; p. 295-6.
  10. Mercer MA, McKenzie HC, Davis JL, Wilson KE, Hodgson DR, Cecere TE. Pharmacokinetics and safety of repeated oral dosing of acetaminophen in adult horses.. Equine Vet J 2020;52(1):120-5.
  11. Ward B, Alexander-Williams JM. Paracetamol revisited: a review of the pharmacokinetics and pharmacodynamics.. Acute Pain 1999;2(3):139-49.
  12. Foreman JH, Bergstrom BE, Golden KS, Roark JJ, Coren DS, Foreman CR. Dose titration of the clinical efficacy of intravenously administered flunixin meglumine in a reversible model of equine foot lameness.. Equine Vet J 2012;44:17-20.
  13. Hoerdemann M, Smith RL, Hosgood G. Duration of action of mepivacaine and lidocaine in equine palmar digital perineural blocks in an experimental lameness model.. Vet Surg 2017;46(7):986-93.
  14. Schumacher J, Schumacher J, Graves F, Steiger R, Schramme M, Smith R. A comparison of the effects of two volumes of local analgesic solution in the distal interphalangeal joint of horses with lameness caused by solar toe or solar heel pain.. Equine Vet J 2010;33(3):265-8.
  15. Merkens HW, Schamhardt HC. Evaluation of equine locomotion during different degrees of experimentally induced lameness I. Lameness model and quantification of ground reaction force patterns of the limbs.. Equine Vet J 2010;20:99-106.
  16. Smith BP, Vandenhende FR, DeSante KA, Farid NA, Welch PA, Callaghan JT. Confidence interval criteria for assessment of dose proportionality.. Pharm Res 2000;17:1278-83.
  17. Keegan KG, Dent EV, Wilson DA, Janicek J, Kramer J, Lacarrubba A. Repeatability of subjective evaluation of lameness in horses.. Equine Vet J 2010;42(2):92-7.
  18. Labens R, Schramme MCA, ARS B. Orthopaedics 1. Diagnosis of lameness/diseases of joints and bones.. In: Mair TS, Love S, Schumacher J, Smith RKW, Frazer G, editors. Equine medicine, surgery and reproduction. 2nd ed. Oxford: W.B. Saunders; 2012. p. 309-28.
  19. Engelking LR, Blyden GT, Lofstedt J, Greenblatt DJ. Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses.. J Vet Pharmacol Ther 1987;10(1):73-82.
  20. Neirinckx E, Vervaet C, De Boever S, Remon JP, Gommeren K, Daminet S. Species comparison of oral bioavailability, first-pass metabolism and pharmacokinetics of acetaminophen.. Res Vet Sci 2010;89(1):113-9.
  21. Moore RA, Derry S, Wiffen PJ, Straube S. Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs-a systematic review.. Br J Clin Pharmacol 2015;80(3):381-8.
  22. Anderson BJ, Holford NHG. Rectal paracetamol dosing regimens: determination by computer simulation.. Paediatr Anaesth 1997;7(6):451-5.
  23. Ishii H, Obara T, Kijima-Suda I. Investigation of plasma concentrations of paracetamol, metacetamol, and orthocetamol in Japanese racehorses using liquid chromatography-electrospray ionisation-tandem mass spectrometry.. Drug Test Anal 2020;12:929-37.
  24. Pesko B, Habershon-Butcher J, Muir T, Gray B, Taylor P, Fenwick S. Pharmacokinetics of paracetamol in the thoroughbred horse following an oral multidose administration.. J Vet Pharmacol Ther 2021;1-9.
  25. Brunner TJ, Lescun TB, Moore GE, Grady SE, Davern AJ, Taylor SD. Induction of noninflammatory pain in an experimental foot lameness model in horses.. J Equine Vet Sci 2020;87:102925.
  26. UCVM Class of 2016, Banse H, Cribb AE. Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse.. Can Vet J 2017;58(2):157-67.
  27. Lees P, Giraudel J, Landoni MF, Toutain PL. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.. J Vet Pharmacol Ther 2004;27:491-502.
  28. Maitho TE, Lees P, Taylor JB. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies.. J Vet Pharmacol Ther 1986;9(1):26-39.
  29. Lees P, Taylor JBO, Higgins AJ, Sedgwick AD. In vitro and in vivo binding of phenylbutazone and related drugs to equine feeds and digesta.. Res Vet Sci 1988;44(1):50-6.
  30. Dyson S. Can lameness be graded reliably?. Equine Vet J 2011;43(4):379-82.
  31. Hardeman AM, Egenvall A, Serra Bragança FM, Swagemakers J-H, Koene MHW, Roepstorff L. Visual lameness assessment in comparison to quantitative gait analysis data in horses.. Equine Vet J 2022;1-10.
    doi: 10.1111/evj.13545google scholar: lookup
  32. Rietmann TR, Staﾬher M, Bernasconi P, Auer JA, Weishaupt MA. The association between heart rate, heart rate variability, endocrine and behavioural pain measures in horses suffering from laminitis.. J Vet Med Series A 2004;51(5):218-25.
  33. Rietmann TR, Stuart AEA, Bernasconi P, Staﾬher M, Auer JA, Weishaupt MA. Assessment of mental stress in warmblood horses: heart rate variability in comparison to heart rate and selected behavioural parameters.. Appl Anim Behav Sci 2004;88(1):121-36.
  34. Reid K, Rogers CW, Gronqvist G, Gee EK, Bolwell CF. Anxiety and pain in horses measured by heart rate variability and behavior.. J Vet Behav 2017;22:1-6.
  35. Guzzetti S, Rovere MTL, Pinna GD, Maestri R, Borroni E, Porta A. Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure.. Eur Heart J 2005;26(4):357-62.

Citations

This article has been cited 3 times.
  1. Patton ME, Andrews FM, Bogers SH, Wong D, McKenzie HC 3rd, Werre SR, Byron CR. Effects of Bit Chewing on Gastric Emptying, Small Intestinal Transit, and Orocecal Transit Times in Clinically Normal Horses.. Animals (Basel) 2023 Aug 4;13(15).
    doi: 10.3390/ani13152518pubmed: 37570326google scholar: lookup
  2. Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses.. Animals (Basel) 2023 May 10;13(10).
    doi: 10.3390/ani13101597pubmed: 37238029google scholar: lookup
  3. Mercer MA, Davis JL, McKenzie HC, Messenger KM, Schaefer E, Council-Troche RM, Werre SR. Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia.. J Vet Intern Med 2023 Mar;37(2):718-727.
    doi: 10.1111/jvim.16663pubmed: 36840424google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.